4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-010508
SVP and CFO sold 1,961 shares at an average $324.96 ($637,248)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dier Mardi SVP and CFO | 2025-03-03 | Sale 10b5-1 | −1,187 | $325.89 | $386,831 | 7,688 | D |
| Dier Mardi SVP and CFO | 2025-03-03 | Sale 10b5-1 | −774 | $323.54 | $250,417 | 6,914 | D |
| Open-market sales · 1,961 sh · avg $324.96 · $637,248 | |||||||
Loading xslF345X05/wk-form4_1741210303.xml…